Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Incyte Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
INCY
Nasdaq
2834
https://www.incyte.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Incyte Corp
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
- Apr 25th, 2024 6:28 pm
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 24th, 2024 2:01 pm
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
- Apr 23rd, 2024 2:01 pm
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
- Apr 23rd, 2024 1:44 pm
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
- Apr 23rd, 2024 11:00 am
The past three years for Incyte (NASDAQ:INCY) investors has not been profitable
- Apr 15th, 2024 1:14 pm
Certain Biotech Investors Get an Early Look at Results. Is That Fair?
- Apr 15th, 2024 9:30 am
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
- Apr 12th, 2024 1:00 pm
Incyte to Report First Quarter Financial Results
- Apr 11th, 2024 12:00 pm
Biotech Executive Who Bet on Rival’s Stock Committed Insider Trading, Jury Says
- Apr 6th, 2024 12:56 pm
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
- Apr 1st, 2024 12:30 pm
12 Best S&P 500 Stocks To Buy According to Analysts
- Mar 31st, 2024 3:53 pm
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 29th, 2024 8:30 pm
Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
- Mar 27th, 2024 3:00 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
- Mar 14th, 2024 3:30 pm
Incyte (INCY) Posts Positive Results on Opzelura From HS Study
- Mar 12th, 2024 5:52 pm
Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead
- Mar 11th, 2024 5:02 pm
Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis
- Mar 10th, 2024 8:05 pm
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa
- Mar 10th, 2024 8:05 pm
Scroll